Cell Line Development Market, By Product, By Type of Cell Lines, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
보고서 하이라이트
세포주 개발(Cell Line Development) 시장 규모는 2022년 48억 1,000만 달러에서 2023년부터 2030년까지 CAGR 9.81%로 추이하며 성장 할 것으로 예상됩니다.
세포주 개발 타켓 시장-시장 역학
바이오의약품과 맞춤형 의료 수요 증가가 시장 수요를 촉진
바이오 의약품 산업의 확대는 단클론항체 및 유전자 치료와 같은 복잡한 바이오 의약품의 생산에 적합한 신뢰성 있고 생산성이 높은 세포주에 대한 수요를 증가시키고 있습니다. 또한, 맞춤형 의료가 중시되게 됨으로써, 주문제작의 의약품을 제작해, 전임상시험을 촉진하기 위한 환자 특이적 세포주의 필요성이 강조되고 있습니다. 이 요구는 보다 탄력적이고 높은 수율로 다목적 세포주 수립을 목표로 하는 현재 진행 중인 R&D 노력을 뒷받침하고 있습니다. 그 결과 광범위한 질병과 병태를 대상으로 하는 새로운 표적 치료제의 진보와 이용이 촉진됩니다.
세포주 개발 시장-주요 인사이트
우리의 연구 분석가의 연구 결과에 따르면 세계의 세포주 개발 시장은 2023년부터 2030년까지의 예측 기간 동안 약 4.2%의 연간 성장률을 전망하고 있습니다.
세포주 개발 분야는 주로 수의학 종양학 분야에서 정밀의료에 대한 관심 증가로 인해 크게 확대될 것으로 예상됩니다.
제품별 세분화에서 시약과 배지는 2022년 주요 카테고리로 떠올랐습니다.
세포주 유형별로 2022년 제품 카테고리에서 재조합 세포주가 선도했습니다.
지역별로는 아시아 태평양이 2022년 수익을 이끌었습니다.
세포주 개발 시장-세분화 분석 :
세계의 세포주 개발 시장은 제품, 세포주 유형, 용도 및 지역을 포함한 여러 주요 차원으로 구성되어 있습니다.
제품 분류에서 시장은 네 가지 주요 부문로 구분됩니다 : 시약, 배지, 장비, 액세서리 및 소모품, 서비스. 특히 시약과 배지는 이 분류에서 우선합니다. 세포주 개발은 다양한 특수 시약과 세포 배양 배지에 크게 의존합니다. 이러한 필수 성분 수요는 세포 성장, 유지, 생산성을 위한 이상적인 환경을 제공할 필요성에 의해 추진되고 있습니다. 이 제품은 연구 및 바이오 제조 분야에서 적용되는 고품질 세포주의 수립과 유지에 필수적인 도구입니다.
세포주 개발 시장-지리적 통찰
지리적 관점에서 보면 이 시장은 북미, 남미, 유럽, 아시아 태평양, 중동, 아프리카 등 폭넓은 지역을 망라하고 있습니다. 이 지역 내에서 개별 국가는 사업 활동을 육성하는데 중요한 역할을 합니다. 아시아 태평양에서는 세포주 개발 서비스와 전문 지식에 대한 수요가 꾸준히 증가하고 있습니다. 이 동향은 많은 요인에 기인합니다. 첫째, 이 지역의 생명공학과 제약 부문의 급성장은 의약품의 연구 개발을 촉진하기 위한 신뢰할 수 있는 세포주에 대한 필요성을 높이고 있습니다.
세포주 개발 시장-경쟁 구도 :
세포주 개발경쟁 구도은 전통 기업과 신흥 기업이 혼합되어 있습니다. Lonza, Thermo Fisher Scientific, WuXi Biologics와 같은 기업은 종합적인 서비스와 기술을 제공합니다. 이러한 기업들은 혁신, 규모, 전문 지식을 어필함으로써 경쟁에 도전하고 있습니다. 한편, 셀렉시스와 소렌팀과 같은 중소기업은 특정 틈새 시장에 초점을 맞추어 전문화된 솔루션과 최첨단 플랫폼을 제공합니다.
목차
제1장 세포주 개발 시장 개요
제2장 주요 요약
제3장 세포주 개발의 주요 시장 동향
- 시장 성장 촉진 요인
- 시장 성장 억제 요인
- 시장 기회
- 향후 시장 동향
제4장 세포주 개발 산업 조사
- PEST 분석
- Porter's Five Forces 분석
- 성장 전망 맵핑
- 규제 틀 분석
제5장 세포주 개발 시장 : COVID-19의 영향 분석
- COVID-19 이전의 영향 분석
- COVID-19 후의 영향 분석
제6장 세포주 개발 시장 상황
- 세포주 개발 시장 점유율 분석(2022년)
- 주요 제조업체별 분석 데이터
제7장 세포주 개발 시장-제품별
- 개요
- 제품별 부문 점유율 분석
- 시약 및 배지
- 장치
- 부속품 및 소모품
- 서비스
제8장 세포주 개발 시장-세포주 유형별
- 개요
- 세포주 유형별 부문 점유율 분석
- 재조합 세포주
- 하이브리드 마스
- 연속 세포주
- 1차 세포주
제9장 세포주 개발 시장-용도별
- 개요
- 용도별 부문 점유율 분석
- 생물생산
- 창약
- 독성시험
- 인간 조직 공학
- 기타
제10장 세포주 개발 시장-지역별
- 소개
- 북미
- 유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
- 아시아 태평양(APAC)
- 개요
- 아시아 태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
- 남미
- 개요
- 남미의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
- 중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타
제11장 주요 벤더 분석-세포주 개발 산업
- 경쟁 대시보드
- 기업 개요
- Lonza
- Thermo Fisher Scientific
- WuXi Biologics
- Catalent
- Selexis
- Horizon Discovery
- Sartorius
- MilliporeSigma
- Abcam
- ATCC
- Crown Bioscience
- LakePharma
- ProBioGen
- Solentim
- Horizon Therapeutics
제12장 애널리스트의 전방위 전망
LYJ
REPORT HIGHLIGHT
Cell Line Development Market size was valued at USD 4,810 Million in 2022, expanding at a CAGR of 9.81 % from 2023 to 2030.
Cell line development represents a pivotal procedure in the biotechnology and pharmaceutical sectors, involving the creation and curation of specialized cells capable of sustained replication and the expression of desired proteins or traits. Typically, these cells are sourced from either animal or human tissues. These well-established cell lines serve as indispensable tools for research, drug discovery, and the large-scale production of biomanufactured products. The process encompasses cell isolation, modification, and thorough characterization to ensure stability and productivity. Cell lines play an integral role in the manufacturing of biopharmaceuticals, vaccines, and disease-related research, significantly expediting scientific advancements and enabling the efficient development of novel medicines and bioproducts catering to diverse medical and industrial applications.
Cell Line Development Market- Market Dynamics
Growing demand for biopharmaceuticals and personalized medicine propel market demand
The expanding biopharmaceutical industry creates a rising demand for reliable and productive cell lines suitable for the production of complex biotherapeutics, including monoclonal antibodies and gene therapies. Additionally, the emphasis on personalized medicine underscores the necessity for patient-specific cell lines to craft tailored medications and facilitate preclinical testing. This requirement fuels ongoing research and development endeavors aimed at establishing more resilient, high-yield, and versatile cell lines. This, in turn, expedites the advancement and accessibility of novel, targeted therapeutics for a wide spectrum of diseases and medical conditions.
Cell Line Development Market- Key Insights
According to our research analyst's findings, the global Cell Line Development market anticipates an annual growth rate of approximately 4.2% during the forecast period spanning from 2023 to 2030.
The Cell Line Development sector is poised for substantial expansion, primarily attributed to the growing focus on precision medicine within the field of veterinary oncology.
When considering the segmentation by Product, Reagent and Media emerged as the dominant category in the year 2022.
In terms of Type of Cell Lines, Recombinant cell lines took the lead in the Product category in 2022.
Geographically, Asia Pacific led the way in revenue generation in the year 2022.
Cell Line Development Market- Segmentation Analysis:
The global Cell Line Development Market is structured around several key dimensions, including Product, Type of Cell Lines, Application, and Region.
In terms of Product categorization, the market is delineated into four main segments: Reagent and Media, Equipment, Accessories and Consumables, and Services. Notably, Reagent and Media take precedence in this classification. The development of cell lines relies heavily on a variety of specialized reagents and cell culture media. The demand for these essential components is propelled by the necessity to provide an ideal environment for cell growth, maintenance, and productivity. These products are indispensable tools in the establishment and sustenance of high-quality cell lines for applications in both research and biomanufacturing.
Cell Line Development Market- Geographical Insights
From a geographical standpoint, this market encompasses a wide array of regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a significant role in fostering business activities. The demand for cell line development services and expertise has been steadily on the rise in the Asia-Pacific region. This trend can be attributed to a multitude of factors. Firstly, the burgeoning biotechnology and pharmaceutical sectors in the region have amplified the necessity for reliable cell lines to facilitate drug research and development efforts.
Cell Line Development Market- Competitive Landscape:
The competitive landscape in cell line development is a blend of well-established and emerging enterprises. Companies like Lonza, Thermo Fisher Scientific, and WuXi Biologics offer a comprehensive suite of services and technologies. They engage in competition by showcasing technical innovation, scale, and expertise. On the other hand, smaller firms like Selexis and Solentim focus on specific niches, delivering specialized solutions and cutting-edge platforms.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CELL LINE DEVELOPMENT MARKET KEY PLAYERS
- Lonza
- Thermo Fisher Scientific
- WuXi Biologics
- Catalent
- Selexis
- Horizon Discovery
- Sartorius
- MilliporeSigma
- Abcam
- ATCC
- Crown Bioscience
- LakePharma
- ProBioGen
- Solentim
- Horizon Therapeutics
GLOBAL CELL LINE DEVELOPMENT MARKET, BY PRODUCT
- Reagent and Media
- Equipment
- Accessories and consumables
- Services
GLOBAL CELL LINE DEVELOPMENT MARKET, BY TYPE OF CELL LINES
- Recombinant cell lines
- Hybridomas
- Continuous cell lines
- Primary cell lines
GLOBAL CELL LINE DEVELOPMENT MARKET, BY APPLICATION
- Bioproduction
- Drug discovery
- Toxicity testing
- Tissue engineering
- Others
GLOBAL CELL LINE DEVELOPMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Cell Line Development Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Cell Line Development Market Snippet by Product
- 2.1.2. Cell Line Development Market Snippet by Type of Cell Lines
- 2.1.3. Cell Line Development Market Snippet by Application
- 2.1.4. Cell Line Development Market Snippet by Country
- 2.1.5. Cell Line Development Market Snippet by Region
- 2.2. Competitive Insights
3. Cell Line Development Key Market Trends
- 3.1. Cell Line Development Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Cell Line Development Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Cell Line Development Market Opportunities
- 3.4. Cell Line Development Market Future Trends
4. Cell Line Development Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Cell Line Development Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Cell Line Development Market Landscape
- 6.1. Cell Line Development Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Cell Line Development Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
- 7.1.2. Reagent and Media
- 7.1.3. Equipment
- 7.1.4. Accessories and consumables
- 7.1.5. Services
8. Cell Line Development Market - By Type of Cell Lines
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Type of Cell Lines, 2022 & 2030 (%)
- 8.1.2. Recombinant cell lines
- 8.1.3. Hybridomas
- 8.1.4. Continuous cell lines
- 8.1.5. Primary cell lines
9. Cell Line Development Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 9.1.2. Bioproduction
- 9.1.3. Drug discovery
- 9.1.4. Toxicity testing
- 9.1.5. Tissue engineering
- 9.1.6. Others
10. Cell Line Development Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Cell Line Development Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Cell Line Development Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Cell Line Development Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Cell Line Development Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Cell Line Development Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Type of Cell Lines, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Cell Line Development Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Lonza
- 11.2.2. Thermo Fisher Scientific
- 11.2.3. WuXi Biologics
- 11.2.4. Catalent
- 11.2.5. Selexis
- 11.2.6. Horizon Discovery
- 11.2.7. Sartorius
- 11.2.8. MilliporeSigma
- 11.2.9. Abcam
- 11.2.10. ATCC
- 11.2.11. Crown Bioscience
- 11.2.12. LakePharma
- 11.2.13. ProBioGen
- 11.2.14. Solentim
- 11.2.15. Horizon Therapeutics
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
